Breast Cancer Liquid Biopsy Market by Competitive Landscape (Collaboration, Acquisition, Mergers, Competitive technology), Platform Comparison, Region, End User, Investments, Market Dynamics, Circulating Biomarkers – 2019 to 2022

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: April 1, 2020
Clear
SKU: GMS-1225 Category:

The global market for breast cancer liquid biopsy is expected to reach USD 605 million by 2024, growing over the forecast period at a CAGR of 21.2%. Factors such as increased breast cancer prevalence, increasing preference for non-invasive procedures, government and global health programs, increased emphasis on personalized medicine in clinical practice, and increased funding for R&D on liquid biopsy are driving market growth.

Breast Cancer Liquid Biopsy Market by Competitive Landscape (Collaboration, Acquisition, Mergers, Competitive technology), Platform Comparison, Region, End User, Investments, Market Dynamics, Circulating Biomarkers - 2019 to 2022 1

Breast Cancer Liquid Biopsy Market by Competitive Landscape (Collaboration, Acquisition, Mergers, Competitive technology), Platform Comparison, Region, End User, Investments, Market Dynamics, Circulating Biomarkers - 2019 to 2022 2

Breast Cancer Liquid Biopsy Market by Competitive Landscape (Collaboration, Acquisition, Mergers, Competitive technology), Platform Comparison, Region, End User, Investments, Market Dynamics, Circulating Biomarkers - 2019 to 2022 3

Breast Cancer Liquid Biopsy Market by Competitive Landscape (Collaboration, Acquisition, Mergers, Competitive technology), Platform Comparison, Region, End User, Investments, Market Dynamics, Circulating Biomarkers - 2019 to 2022 4

Breast Cancer Liquid Biopsy Market by Competitive Landscape (Collaboration, Acquisition, Mergers, Competitive technology), Platform Comparison, Region, End User, Investments, Market Dynamics, Circulating Biomarkers - 2019 to 2022 5

Breast Cancer Liquid Biopsy Market by Competitive Landscape (Collaboration, Acquisition, Mergers, Competitive technology), Platform Comparison, Region, End User, Investments, Market Dynamics, Circulating Biomarkers - 2019 to 2022 6

Breast Cancer Liquid Biopsy Market by Competitive Landscape (Collaboration, Acquisition, Mergers, Competitive technology), Platform Comparison, Region, End User, Investments, Market Dynamics, Circulating Biomarkers - 2019 to 2022 7

Breast Cancer Liquid Biopsy Market by Competitive Landscape (Collaboration, Acquisition, Mergers, Competitive technology), Platform Comparison, Region, End User, Investments, Market Dynamics, Circulating Biomarkers - 2019 to 2022 8

1 Global Breast Cancer Liquid Biopsy Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Breast Cancer Liquid Biopsy Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Breast Cancer Liquid Biopsy Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Breast Cancer Liquid Biopsy Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Breast Cancer Liquid Biopsy Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Breast Cancer Liquid Biopsy Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Breast Cancer Liquid Biopsy Market – By Circulating Biomarker (Market Size – &
million/billion)
8.1 Circulating Tumor Cells (CTCs)
8.2 Cell-free DNA (cfDNA)
8.3 Extracellular Vesicles (EVs)
8.4 Other

9 Global Breast Cancer Liquid Biopsy Market – By End-User
9.1 Reference Laboratories
9.2 Hospitals and Physician Laboratories
9.3 Other

10 Global Breast Cancer Liquid Biopsy Market – By Geography (Market Size – &
million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa

11 Global Breast Cancer Liquid Biopsy Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships

12 Global Breast Cancer Liquid Biopsy Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 Company 1
12.3 Company 2
12.4 Company 3
12.5 Company 4
12.6 Company 5
12.7 Company 6
12.8 Company 7
12.9 Company 8
12.10 Company 9
12.11 Company 10
12.12 Company 11 & more

13 Global Breast Cancer Liquid Biopsy Market – Appendix
13.1 Sources
13.2 Abbreviations